Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Future Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2217/fon.13.161PMID 24328410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review of recent studies on interventions for cognitive deficits in patients with cancer

  2012cited by this paper
• Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments

  2012cited by this paper
• Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation

  2012cited by this paper
• Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation

  2011cited by this paper
• Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia.

  2010cited by this paper
• Cancer-related fatigue and its associations with depression and anxiety: a systematic review.

  2009cited by this paper
• Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

  2009cited by this paper
• Two faces for Janus: recombinant human erythropoiesis-stimulating agents and cancer mortality

  2009cited by this paper
• Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study.

  2009cited by this paper
• Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies including 2301 patients

  2008cited by this paper
• Is cancer-related fatigue more strongly correlated to haematological or to psychological factors in cancer patients?

  2008cited by this paper
• Editorial: anemia management with erythropoiesis-stimulating agents: a risk-benefit update.

  2008cited by this paper
• Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.

  2008cited by this paper
• The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

  2004cited by this paper
• The relationship between psychologic distress and cancer‐related fatigue

  2003cited by this paper
• Impact of epoetin β on quality of life in patients with malignant disease

  2003cited by this paper
• Hemoglobin increase is associated with improved health-related quality of life in patients with cancer not receiving chemotherapy.

  2003cited by this paper
• Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

  2002cited by this paper
• Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

  2002cited by this paper
• Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy

  2001cited by this paper
• Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

  2001cited by this paper
• Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy.

  2001cited by this paper
• Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum.

  2000cited by this paper
• Chemotherapy-induced anemia in adults: incidence and treatment.

  1999cited by this paper
• Transfusion medicine. First of two parts--blood transfusion.

  1999cited by this paper
• Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.

  1998cited by this paper
• Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer.

  1998cited by this paper
• Factors influencing quality of life in cancer patients: anemia and fatigue.

  1998cited by this paper
• The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.

  1997cited by this paper
• Assessing psychological distress in cancer patients: validation of a self-administered questionnaire.

  1996cited by this paper
• The Frequency of Red Cell Transfusion for Anemia in Patients Receiving Chemotherapy A Retrospective Cohort Study

  1993cited by this paper
• Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

  1993cited by this paper
• Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer.

  1992cited by this paper
• Erythropoietin treatment of anemia associated with multiple myeloma.

  1990cited by this paper
• Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

  1986cited by this paper

• Immunoregulation role of the erythroid cells

  2024cites this paper
• FACTORS ASSOCIATED WITH INCREASED RED BLOOD CELLS TRANSFUSION REQUIREMENTS IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA.

  2015cites this paper